<code id='19F5F2B47A'></code><style id='19F5F2B47A'></style>
    • <acronym id='19F5F2B47A'></acronym>
      <center id='19F5F2B47A'><center id='19F5F2B47A'><tfoot id='19F5F2B47A'></tfoot></center><abbr id='19F5F2B47A'><dir id='19F5F2B47A'><tfoot id='19F5F2B47A'></tfoot><noframes id='19F5F2B47A'>

    • <optgroup id='19F5F2B47A'><strike id='19F5F2B47A'><sup id='19F5F2B47A'></sup></strike><code id='19F5F2B47A'></code></optgroup>
        1. <b id='19F5F2B47A'><label id='19F5F2B47A'><select id='19F5F2B47A'><dt id='19F5F2B47A'><span id='19F5F2B47A'></span></dt></select></label></b><u id='19F5F2B47A'></u>
          <i id='19F5F2B47A'><strike id='19F5F2B47A'><tt id='19F5F2B47A'><pre id='19F5F2B47A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:1
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          STAT Summit: How researchers deal with rejection
          STAT Summit: How researchers deal with rejection

          Fromlefttoright:BrendaCabrera-Mendoza,LaurenGhazal,andZhiYuatthe2023STATSummit.STATAttheageof26,Laur

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Congress must reauthorize a committee to support older Americans

          OlderadultsandfirstresponderswaitinlinetoreceiveaCovid-19vaccineattheLakesRegionalLibraryinDecember2